Ignite Creation Date:
2024-05-06 @ 1:51 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04142060
Status:
TERMINATED
Last Update Posted:
2022-10-28
First Post:
2019-10-25
Brief Title:
Targeting the PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-PositiveHer2-Negative Metastatic BC
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
SOLTI Breast Cancer Research Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-25
First Submit QC Date:
October 28 2019
Study First Post Date:
2019-10-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-25
Last Update Post Date:
2022-10-28
Last Update Post Date Type:
ACTUAL